Advertisement

Drugs & Therapy Perspectives

, Volume 22, Issue 9, pp 12–15 | Cite as

Managing atrial fibrillation after coronary artery bypass graft surgery involves prophylaxis, cardioversion and/or ventricular rate control

Disease Management
  • 29 Downloads

References

  1. 1.
    Hilleman DE, Hunter CB, Mohiuddin SM, et al. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs 2005; 5(6): 361–9PubMedCrossRefGoogle Scholar
  2. 2.
    Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94(3): 390–7PubMedCrossRefGoogle Scholar
  3. 3.
    Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276(4): 300–6PubMedCrossRefGoogle Scholar
  4. 4.
    Lauer MS, Eagle KA, Buckley MJ, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–78PubMedCrossRefGoogle Scholar
  5. 5.
    Rubin DA, Nieminski KE, Reed GE, et al. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987; 94: 331–5PubMedGoogle Scholar
  6. 6.
    Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J 2000; 140: 871–7PubMedCrossRefGoogle Scholar
  7. 7.
    Fuller JA, Adams GC, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J Thorac Cardiovas Surg 1989; 97: 821–5Google Scholar
  8. 8.
    Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32: 1508–13PubMedCrossRefGoogle Scholar
  9. 9.
    Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56(3): 539–49PubMedCrossRefGoogle Scholar
  10. 10.
    Hravnak M, Hoffman LA, Saul MI, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002; 11: 228–38PubMedGoogle Scholar
  11. 11.
    Weintraub WS, Becker ER, Mauldin PD, et al. Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). Am J Cardiol 2000; 86: 747–52PubMedCrossRefGoogle Scholar
  12. 12.
    Doering LV, Esmailian F, Laks H. Perioperative predictors of ICU and hospital costs in coronary artery bypass graft surgery. Chest 2000; 118: 736–43PubMedCrossRefGoogle Scholar
  13. 13.
    Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation 1991; 84Suppl. III: 236–44Google Scholar
  14. 14.
    Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2004 Oct 18; (4): CD003611PubMedGoogle Scholar
  15. 15.
    Kowey PR, Taylor JE, Rials SJ, et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69: 963–5PubMedCrossRefGoogle Scholar
  16. 16.
    Miller S, Crystal E, Garfinkle M, Lau C, et al. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005; 91(5): 618–23PubMedCrossRefGoogle Scholar
  17. 17.
    Martinez EA, Epstein AE, Bass EB, et al. Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005 Aug; 128(2 Suppl.): 56S–60SPubMedCrossRefGoogle Scholar
  18. 18.
    Pfisterer ME, Kloter-Weber UC, Huber M, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surg 1997; 64: 1113–9PubMedCrossRefGoogle Scholar
  19. 19.
    Forlani S, De Paulis R, de Notaris S, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002; 74: 720–6PubMedCrossRefGoogle Scholar
  20. 20.
    Gomes JA, Ip J, Santoni-Rugin F, et al. Oral d, l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34: 334–9PubMedCrossRefGoogle Scholar
  21. 21.
    Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004; 148(4): 641–8PubMedCrossRefGoogle Scholar
  22. 22.
    Tisdale JE, Padhi ID, Goldberg AD, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998; 135: 739–47PubMedCrossRefGoogle Scholar
  23. 23.
    Hilleman DE, Reyes AP, Mooss AN, et al. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin 2003; 19: 376–82PubMedCrossRefGoogle Scholar
  24. 24.
    Olshansky B. Management of atrial fibrillation after coronary artery bypass graft surgery. Am J Cardiol 1996; 78: 27–34PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Personalised recommendations